Stock listing
BOATS:BIAF bioAffinity Technologies, Inc. Stock
US listing (BOATS) of bioAffinity Technologies, Inc. · home listing NASDAQ:BIAF
Follow bioAffinity Technologies, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:BIAF
$2.91 USD -0.12 (-4.0%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:BIAF
- Day range
- $2.86 – $3.04 USDOct 30, 2026
- Volume
- 46,406 sharesOct 30, 2026
- Market cap
- $3.73M USDAt the close on Oct 30, 2026 · price × 1.28M shares outstanding
- 52-week range
- $2.66 – $80.70 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $30.71M USDMedian day 122,658 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BIAF · Home | $2.91 USD | -0.12 (-4.0%) | 46,406 | $3.04 | $3.04 | $2.861 | $3.03 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:BIAF · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.91 | -0.12 | -4.0% | $3.04 | $3.04 | $2.861 | 46,406 | |
| $3.03 | -0.11 | -3.5% | $3.02 | $3.29 | $2.99 | 325,549 | |
| $3.14 | +0.18 | +6.1% | $2.914 | $3.16 | $2.84 | 54,729 | |
| $2.96 | +0.13 | +4.6% | $2.81 | $3.14 | $2.75 | 188,570 | |
| $2.83 | +0.03 | +1.1% | $2.80 | $2.88 | $2.66 | 70,426 | |
| $2.80 | -0.37 | -11.7% | $3.17 | $3.265 | $2.80 | 124,590 | |
| $3.17 | -0.40 | -11.2% | $3.50 | $3.73 | $3.14 | 90,624 | |
| $3.57 | -0.09 | -2.5% | $3.68 | $3.69 | $3.54 | 64,795 | |
| $3.66 | +0.15 | +4.3% | $3.44 | $3.75 | $3.44 | 89,086 | |
| $3.51 | -0.22 | -5.9% | $3.67 | $3.69 | $3.43 | 72,982 | |
| $3.73 | -0.23 | -5.8% | $3.95 | $3.95 | $3.60 | 101,847 | |
| $3.96 | +0.40 | +11.2% | $3.47 | $4.10 | $3.406 | 278,093 | |
| $3.56 | -0.065 | -1.8% | $3.42 | $3.68 | $3.411 | 120,725 | |
| $3.625 | -0.275 | -7.1% | $3.52 | $3.74 | $3.23 | 892,274 | |
| $3.90 | -0.825 | -17.5% | $4.75 | $4.75 | $3.76 | 284,992 | |
| $4.725 | -0.915 | -16.2% | $5.41 | $5.48 | $4.68 | 657,427 | |
| $5.64 | -0.52 | -8.4% | $6.35 | $9.38 | $5.50 | 35,253,385 | |
| $6.16 | +0.10 | +1.7% | $5.90 | $6.28 | $5.86 | 87,687 | |
| $6.06 | -0.13 | -2.1% | $6.56 | $6.598 | $5.90 | 259,250 | |
| $6.19 | +0.135 | +2.2% | $5.93 | $6.20 | $5.85 | 106,502 | |
| $6.055 | -0.09 | -1.5% | $6.06 | $6.235 | $5.90 | 154,642 | |
| $6.145 | -0.415 | -6.3% | $6.56 | $6.865 | $6.07 | 247,549 | |
| $6.56 | -0.32 | -4.7% | $6.56 | $7.00 | $6.56 | 108,540 | |
| $6.88 | -0.53 | -7.2% | $7.31 | $7.34 | $6.66 | 150,294 | |
| $7.41 | -0.52 | -6.6% | $7.74 | $8.00 | $7.27 | 481,316 | |
| $7.93 | +0.10 | +1.3% | $7.815 | $7.96 | $7.67 | 129,343 | |
| $7.83 | -0.11 | -1.4% | $7.67 | $8.00 | $7.50 | 220,567 | |
| $7.94 | -0.615 | -7.2% | $8.40 | $8.55 | $7.82 | 207,877 | |
| $8.555 | +0.855 | +11.1% | $8.28 | $9.14 | $8.26 | 874,297 | |
| $7.70 | -1.73 | -18.3% | $8.39 | $8.80 | $7.371 | 757,221 | |
| $9.43 | +0.68 | +7.8% | $10.66 | $12.48 | $9.23 | 10,309,394 | |
| $8.75 | +3.40 | +63.6% | $7.00 | $11.00 | $6.45 | 25,410,034 | |
| $5.35 | -1.01 | -15.9% | $6.01 | $6.31 | $5.11 | 279,118 | |
| $6.36 | -1.57 | -19.8% | $7.14 | $7.317 | $6.03 | 363,062 | |
| $7.93 | -0.02 | -0.3% | $7.71 | $8.23 | $7.50 | 366,869 | |
| $7.95 | -1.44 | -15.3% | $9.96 | $10.08 | $7.82 | 827,861 | |
| $9.39 | -1.11 | -10.6% | $9.53 | $10.49 | $9.38 | 793,879 | |
| $10.50 | +1.57 | +17.6% | $10.90 | $12.32 | $10.09 | 10,455,635 | |
| $8.93 | -6.34 | -41.5% | $10.63 | $10.63 | $8.36 | 2,411,951 | |
| $15.27 | +2.49 | +19.5% | $11.12 | $20.35 | $10.90 | 20,085,150 | |
| $12.78 | +3.03 | +31.1% | $13.20 | $13.58 | $11.06 | 19,253,783 | |
| $9.75 | +3.16 | +48.0% | $7.61 | $11.75 | $7.54 | 46,047,680 | |
| $6.59 | +2.03 | +44.5% | $7.72 | $8.60 | $6.13 | 46,392,727 | |
| $4.56 | -0.31 | -6.4% | $4.83 | $4.98 | $4.56 | 36,149 | |
| $4.87 | -0.19 | -3.8% | $4.95 | $5.17 | $4.87 | 30,377 | |
| $5.06 | -0.03 | -0.6% | $5.00 | $5.13 | $4.96 | 43,404 | |
| $5.09 | -0.10 | -1.9% | $5.19 | $5.32 | $4.88 | 79,678 | |
| $5.19 | -0.63 | -10.8% | $5.40 | $5.47 | $5.08 | 88,772 | |
| $5.82 | -0.18 | -3.0% | $6.02 | $6.35 | $5.725 | 167,437 | |
| $6.00 | -0.002 | 0.0% | $5.76 | $6.297 | $5.477 | 4,563 | |
| $6.002 | -0.133 | -2.2% | $5.793 | $6.674 | $5.475 | 15,071 | |
| $6.135 | -0.965 | -13.6% | $6.771 | $6.771 | $5.868 | 19,098 | |
| $7.10 | +1.22 | +20.7% | $7.982 | $8.547 | $6.525 | 756,209 | |
| $5.88 | -0.152 | -2.5% | $6.225 | $6.30 | $5.775 | 1,515 | |
| $6.032 | +0.287 | +5.0% | $5.85 | $6.206 | $5.783 | 2,258 | |
| $5.745 | -1.346 | -19.0% | $6.795 | $6.90 | $4.878 | 3,746 | |
| $7.091 | -0.199 | -2.7% | $7.35 | $7.35 | $7.05 | 250 | |
| $7.29 | -0.06 | -0.8% | $7.412 | $7.497 | $6.86 | 901 | |
| $7.35 | -0.30 | -3.9% | $7.50 | $7.80 | $7.35 | 2,363 | |
| $7.65 | -0.295 | -3.7% | $7.95 | $7.958 | $7.605 | 2,347 | |
| $7.945 | -0.002 | 0.0% | $7.92 | $7.95 | $7.697 | 963 | |
| $7.947 | -0.309 | -3.7% | $8.40 | $8.847 | $7.695 | 1,265 | |
| $8.256 | -0.705 | -7.9% | $8.85 | $9.068 | $8.25 | 1,360 | |
| $8.961 | -0.45 | -4.8% | $9.135 | $9.30 | $8.702 | 791 | |
| $9.411 | -0.255 | -2.6% | $9.60 | $9.60 | $8.788 | 504 | |
| $9.666 | +0.891 | +10.2% | $8.775 | $9.842 | $8.402 | 800 |
- Ticker
- BOATS:BIAF
- Asset type
- Stock
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
bioAffinity Technologies Highlights Importance of Link Between Early Lung Cancer Detection and Curative Treatment During National Lung Cancer Awareness Month
Latest deck · Sep 11, 2026
Investor Presentation (September 2026)
Investor deck · 19 slides
Calls
Replays
Bioaffinity Technologies (NASDAQ:BIAF) Q4 2022 Earnings Call
Mon, Apr 03, 2023 · 9:00 AM ET
Watch TranscriptBioaffinity Technologies (NASDAQ:BIAF) Q3 2022 Earnings Call
Mon, Nov 14, 2022 · 8:00 AM ET
Watch Transcript
Latest news
bioAffinity Technologies Highlights Importance of Link Between Early Lung Cancer Detection and Curative Treatment During National Lung Cancer Awareness Month
Oct 29, 2026
Closed $3.03 (-3.5%) on Oct 29, 2026
bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026
Oct 15, 2026
Closed $3.96 (+11.2%) on Oct 15, 2026
bioAffinity Technologies to Present Positive Research Data in Development of Its New Test Measuring Asthma and COPD-Related Lung Inflammation and Drug-Related Receptors at CHEST 2026
Oct 13, 2026
Closed $3.63 (-7.1%) on Oct 13, 2026
BioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Oct 9, 2026
Closed $4.73 (-16.2%) on Oct 9, 2026
bioAffinity Technologies Announces Notification of Japanese Patent Allowance Covering Noninvasive CyPath® Lung and AI-Built Algorithm
Oct 8, 2026
Closed $5.64 (-8.4%) on Oct 8, 2026
bioAffinity Technologies Reports Over 100% Growth in CyPath® Lung Sales Through Third Quarter 2026
Oct 6, 2026
Closed $6.06 (-2.1%) on Oct 6, 2026
BioAffinity Technologies Promotes Veteran Awareness and Access to Its Noninvasive CyPath® Lung Cancer Test Through Distribution Partnership with Veteran-Owned AvMEDICAL
Sep 30, 2026
Closed $6.56 (-4.7%) on Sep 30, 2026
BioAffinity Technologies to Present Positive Clinical and Veteran-Focused Data on CyPath® Lung at NAVREF 2026 Annual Conference
Sep 22, 2026
Closed $8.56 (+11.1%) on Sep 22, 2026
BioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath(R) Lung Noninvasive Lung Cancer Diagnostic
Sep 18, 2026
Closed $9.43 (+7.8%) on Sep 18, 2026
BioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic
Sep 17, 2026
Closed $8.75 (+63.6%) on Sep 17, 2026
Financings
Registered direct offering of common stock (or pre-funded warrants in lieu thereof)
Oct 9, 2026
Closed: US$4M raised · US$6.122 a share · WallachBeth Capital, LLC
Dealers: WallachBeth Capital, LLC (lead)
Buyers: institutional investor
Use of proceeds: Working capital, supporting expected growing sales for CyPath Lung, and general corporate purposes
Private placement of warrants to purchase common stock
Oct 9, 2026
Closed: Warrants at US$6.122 for 60 months
Private placement of pre-funded warrants with accompanying warrants
Aug 17, 2026
Closed: US$4M raised · US$0.4657 a share · Warrants at US$0.4727 for 60 months · WallachBeth Capital LLC
Dealers: WallachBeth Capital LLC (lead)
Decks
Investor Presentation (September 2026)
Investor deck · 19 slides · Sep 11, 2026
Investor Presentation (March 2026)
Investor deck · 21 slides · Mar 26, 2026
Investor Presentation (February 2026)
Investor deck · 20 slides · Feb 10, 2026
Investor Presentation (2026)
Investor deck · 20 slides · 2026
bioAffinity Technologies, Inc. on 6ix
- News releases
- 51 in the last 12 months · 133 in all · newest Oct 29, 2026 · oldest 2022
- Calls
- 2 calls with a replay · 2 with a transcript · latest Apr 3, 2023
- Decks
- 6 decks · latest Sep 11, 2026
Where bioAffinity Technologies, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BIAF · Home listing | NASDAQ | United States | USD |
| BOATS:BIAF · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about bioAffinity Technologies, Inc.